Preparation and bioactivity of pyranole derivatives as potential cross-linking agent

Canadian Journal of Chemistry

Volumn 75, Issue 6, 1997, Pages 913-919

  Katayama, H ^a   Oshiyama, T ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Antitumor activity; Cytotoxicity; Polyalkylator; Pyrazole; Synthesis

Indexed keywords

ALKYLATION; BROMINE COMPOUNDS; CHLORINE COMPOUNDS; CROSSLINKING; ONCOLOGY; SYNTHESIS (CHEMICAL); TOXICITY;

ANTITUMOR ACTIVITY; BIOACTIVITY; CYTOTOXICITY; PYRAZOLE DERIVATIVES;

NITROGEN COMPOUNDS;

EID: 0031169114     PISSN: 00084042     EISSN: None     Source Type: Journal    
DOI: 10.1139/v97-109     Document Type: Article

References (31)

1. (a) I.K. Larsen. In A textbook of drug design and development. Edited by P. Krogsgaard-Larsen and H. Bundgaard. Harwood Academic, Chur, Switzerland. 1991. Chap. 6;
2. (b) R.B. Silvermann. In The organic chemistry of drug design and drug action. Academic Press Inc., San Diego, Calif. 1992. Chap. 6.
3. M. Tomasz. In Molecular aspects of anticancer drug - DNA interactions. Vol. 2. Edited by S. Neidle and M. Waring. The Macmillan Press Ltd., London. 1994. Chap. 8.
4. J.A. Hartley. In Molecular aspects of anticancer drug - DNA interactions. Vol. 1. Edited by S. Neidle and M. Waring. The Macmillan Press Ltd., London. 1993. Chap. 1.
5. (a) M.F. Weidner, S.Th. Sigurdsson, and P.B. Hopkins. Biochemistry, 29, 9225 (1990);
6. (b) J. Woo, S.Th. Sigurdsson, and P.B. Hopkins. J. Am. Chem. Soc. 115, 3407 (1993).
7. (a) J.-K. Shen, H. Katayama, N. Takatsu, and I. Shiro. J. Chem. Soc. Perkin Trans. 1, 2087 (1993);
8. (b) J.-K. Shen and H. Katayama. Chem. Pharm. Bull. 42, 214 (1994);
9. (c) Chem. Pharm. Bull. 42, 222 (1994);
10. (d) J.-K. Shen, H. Katayama, and N. Takatsu. Chem. Pharm. Bull. 42, 237 (1994);
11. (e) H. Katayama, Y. Kawada, T. Oshiyama, and A. Ejima. Chem. Pharm. Bull. 44, 1276 (1996).
12. I.L. Finar. J. Chem. Soc. (B), 725 (1968).
13. (a) G. Minunni. Gazz. Chim. Ital. 55, 502 (1925);
14. (b) R. Huisgen, M. Seidel, G. Wallbillich, and H. Knupfer. Tetrahedron, 17, 3 (1962).
15. E. Campaigne and B.F. Tullar. Org. Synth. Coll. Vol. 4, 921 (1963).
16. J. March. In Advanced organic chemistry. 3rd ed. Wiley-Interscience, New York. 1985. p. 353.
17. G.R. Allen, Jr., J.F. Poletto, and M.J. Weiss. J. Org. Chem. 30, 2897 (1965).
18. E.W. Collington and Q.I. Meyers. J. Org. Chem. 36, 3044 (1971).
19. D. Choi, B. Yoo, K.L. Colson, G.E. Martin, and H. Kohn. J. Org. Chem. 60, 3391 (1995).
20. W. Bremser, L. Ernst, B. Franke, R. Gerhards, and A. Hardt. In Carbon-13 NMR spectral data. Verlag Chemie, Weinheim. 1986.
21. (a) R.C. Raynolds. In Cancer chemotherapeutic agents. Edited by W.O. Foye. American Chemical Society. 1995; p. 186;
22. (b) J.A. Maddry. In Cancer chemotherapeutic agents. Edited by W.O. Foye. American Chemical Society. 1995; p. 201.
23. R. Fusco. Gazz. Chim. Ital. 69, 344 (1939); Chem. Abstr. 33, 8609b (1939).
24. R. Fusco. Gazz. Chim. Ital. 69, 344 (1939); Chem. Abstr. 33, 8609b (1939).
25. (a) R.G. Jones and C.W. Whitehead. J. Org. Chem. 20, 1342 (1955);
26. (b) L. Bauer and C.S. Mahajanshetti. J. Heterocycl. Chem. 4, 325 (1967).
27. S. Sasatani, T. Miyazaki, K. Maruoka, and H. Yamamoto. Tetrahedron Lett. 24, 4711 (1983).
28. J. Powell, N. James, and S.J. Smith. Synthesis, 338 (1986).
29. M.R. Harnden and R.L. Jarvest. Tetrahedron Lett. 35, 4265 (1985).
30. M.C. Alley, D.A. Seudiero, A. Monks, M.L. Hursey, M.J. Czerwinski, D.L. Fine, B.J. Abbott, J.G. Mayo, R.M. Shoemaker, and M.R. Byod. Cancer Res. 48, 589 (1988).
31. R.I. Geran, N.H. Greenberg, M.M. Macdonald, A.M. Schumacher, and B.J. Abbott. Cancer Chemother. Rep. Part 3, 3, 7 (1972).